Acadia Pharmaceuticals Inc. (ACAD) scores 54 out of 100 on boothcheck's 11-model valuation framework. Verdict: Poor The estimated fair value is 22.79, representing a 2% margin of safety. Quantitative score: 55/100. Qualitative score: 70/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.